Stryker Corporation (SYK) Receives $134.79 Consensus Price Target from Analysts

Shares of Stryker Corporation (NYSE:SYK) have been given a consensus rating of “Hold” by the twenty-two research firms that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and twelve have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $135.38.

SYK has been the subject of several recent research reports. Deutsche Bank AG reissued a “buy” rating and set a $148.00 price target (up previously from $135.00) on shares of Stryker Corporation in a research report on Saturday, April 29th. Canaccord Genuity reissued a “buy” rating and set a $137.00 price target on shares of Stryker Corporation in a research report on Monday, February 27th. BidaskClub downgraded Stryker Corporation from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Jefferies Group LLC reissued a “hold” rating and set a $132.00 price target on shares of Stryker Corporation in a research report on Thursday, April 13th. Finally, BMO Capital Markets reissued a “hold” rating and set a $125.00 price target on shares of Stryker Corporation in a research report on Tuesday, April 11th.

In related news, insider Timothy J. Scannell sold 13,322 shares of the business’s stock in a transaction dated Tuesday, May 2nd. The stock was sold at an average price of $135.89, for a total value of $1,810,326.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider David Floyd sold 7,381 shares of the business’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $144.70, for a total value of $1,068,030.70. The disclosure for this sale can be found here. 7.40% of the stock is currently owned by insiders.

Institutional investors have recently modified their holdings of the stock. Bessemer Group Inc. increased its position in shares of Stryker Corporation by 12.1% in the fourth quarter. Bessemer Group Inc. now owns 4,954 shares of the medical technology company’s stock worth $594,000 after buying an additional 534 shares during the last quarter. Armor Investment Advisors LLC bought a new position in shares of Stryker Corporation during the fourth quarter worth approximately $581,000. FUKOKU MUTUAL LIFE INSURANCE Co bought a new position in shares of Stryker Corporation during the fourth quarter worth approximately $108,000. State Street Corp increased its position in shares of Stryker Corporation by 3.1% in the fourth quarter. State Street Corp now owns 13,774,848 shares of the medical technology company’s stock worth $1,650,599,000 after buying an additional 419,118 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. increased its position in shares of Stryker Corporation by 2.6% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 164,811 shares of the medical technology company’s stock worth $19,746,000 after buying an additional 4,192 shares during the last quarter. Institutional investors own 74.26% of the company’s stock.

Shares of Stryker Corporation (NYSE SYK) traded up 0.21% during mid-day trading on Monday, hitting $141.10. The stock had a trading volume of 633,001 shares. The stock has a 50 day moving average price of $139.24 and a 200-day moving average price of $129.39. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $145.62. The company has a market cap of $52.74 billion, a PE ratio of 31.71 and a beta of 0.81.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings data on Tuesday, April 25th. The medical technology company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.43 by $0.05. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.33%. The firm had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $2.90 billion. During the same period last year, the business posted $1.24 EPS. Stryker Corporation’s quarterly revenue was up 18.4% on a year-over-year basis. On average, equities analysts expect that Stryker Corporation will post $6.43 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, July 31st. Stockholders of record on Friday, June 30th will be given a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.21%. The ex-dividend date of this dividend is Wednesday, June 28th. Stryker Corporation’s payout ratio is 38.20%.

ILLEGAL ACTIVITY NOTICE: “Stryker Corporation (SYK) Receives $134.79 Consensus Price Target from Analysts” was published by sleekmoney and is the sole property of of sleekmoney. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://sleekmoney.com/stryker-corporation-syk-receives-134-79-consensus-price-target-from-analysts/1931918.html.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/stryker-corporation-syk-receives-134-79-consensus-price-target-from-analysts/1931918.html

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *